FREMONT, Calif., Jul 29, 2009 (BUSINESS WIRE) -- Lam Research Corporation (NASDAQ: LRCX) highlights for the June 2009 quarter were:
(in thousands, except per share data and percentages) | |||||||||||||||||||||||
|
Revenue: |
$ | 217,764 | ||||||||||||||||||||
|
Operating Margin: | U.S. GAAP: | -29.9 | % | Ongoing: | -21.4 | % | ||||||||||||||||
Net Loss: | U.S. GAAP: | $ | (88,490 | ) | Ongoing: | $ | (57,005 | ) | |||||||||||||||
Diluted EPS: | U.S. GAAP: | $ | (0.70 | ) | Ongoing: | $ | (0.45 | ) | |||||||||||||||
Lam Research Corporation today announced financial results for the quarter ended June 28, 2009. Revenue for the period was $217.8 million, gross margin was $67.8 million and net loss was $(88.5) million, or $(0.70) per diluted share, compared to revenue of $174.4 million, gross margin of $36.5 million and net loss of $(198.4) million, or $(1.58) per diluted share, for the March 2009 quarter. Shipments for the June 2009 quarter were $246 million compared to $159 million during the March 2009 quarter.
The Company's ongoing results for the June 2009 quarter exclude certain costs for previously announced restructuring activities and asset impairments, a legal judgment, a non-cash goodwill impairment charge, certain one-time contract termination costs, a net tax expense for valuation allowance, net tax expense on resolution of certain tax matters, and interest and legal fees related to Internal Revenue Code Section 409A tax expenses. The Company's ongoing results for the March 2009 quarter excluded certain costs for previously announced restructuring activities and asset impairments, a non-cash goodwill impairment charge, a net tax expense for a change in state tax law, a net tax expense and an exchange rate gain associated with the Company's accelerated tax planning strategy, an investment impairment, and interest on Internal Revenue Code Section 409A tax expenses. Management uses the presentation of ongoing gross margin, ongoing operating expenses, ongoing operating loss, ongoing operating margin, ongoing net loss, and ongoing net loss per diluted share to evaluate the Company's operating and financial results. The Company believes the presentation of ongoing results is useful to investors for analyzing ongoing business trends and comparing performance to prior periods, and enhances the investor's ability to view the Company's results from management's perspective. A table presenting a reconciliation of ongoing results to results under U.S. GAAP is included at the end of this press release and on the Company's web site.
Ongoing net loss was $(57.0) million, or $(0.45) per diluted share in the June 2009 quarter compared to ongoing net loss of $(89.8) million, or $(0.71) per diluted share, for the March 2009 quarter. Ongoing gross margin for the June 2009 quarter was $67.8 million or 31.1%, compared to ongoing gross margin of $46.7 million, or 26.8%, for the March 2009 quarter. The sequential increase in gross margin was primarily due to improved factory and field utilization due to increased business volume. Ongoing operating expenses for the June 2009 quarter decreased to $114.3 million compared with the March 2009 quarter of $128.9 million. This decrease was driven by a full quarter savings in employee-related expenses and other cost reduction measures that were a part of the March 2009 quarter restructuring. In addition, in the March 2009 quarter, the Company recorded accounts receivable reserves for specific distressed customers that did not recur in the June 2009 quarter.
The geographic distribution of shipments and revenue during the June 2009 quarter is shown in the following table:
Region | Shipments | Revenue | |||||||||
North America | 16% | 18% | |||||||||
Europe | 8% | 10% | |||||||||
Japan | 17% | 17% | |||||||||
Korea | 16% | 14% | |||||||||
Taiwan | 30% | 29% | |||||||||
Asia Pacific | 13% | 12% | |||||||||
Cash and cash equivalents, short-term investments and restricted cash and investments balances were $757.8 million at the end of the June 2009 quarter, compared to $806.4 million at the end of the March 2009 quarter. Cash flows from operating activities were approximately $(58.1) million during the June 2009 quarter. Deferred revenue and deferred profit balances at the end of the June 2009 quarter were $64.7 million and $45.8 million, respectively. Our deferred revenue balance does not include shipments to Japanese customers, to whom title does not transfer until customer acceptance. Shipments to Japanese customers are classified as inventory at cost until the time of acceptance. The anticipated future revenue from shipments to Japanese customers was approximately $13 million as of June 28, 2009.
"Relative to the March quarter, business conditions improved in the June quarter, contributing to Lam's ability to show improved financial results for the quarter. Shipments and revenues increased as a result of customer investments to add wafer starts at the leading edge in both foundry and memory, as well as higher fab utilization contributing to improvement in the customer service business," said Steve Newberry, Lam's president and chief executive officer. "While we are encouraged that our customers have increased spending on equipment, we plan to maintain our focus on cash management while continuing our strategic investments in leading-edge solutions for our customers' current and next-generation wafer fabrication needs," Newberry concluded.
Statements made in this press release which are not statements of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate, but are not limited, to the anticipated revenue from shipments to Japanese customers, the potential uses of our cash and other assets, our business focus on minimizing cash expenditures and making strategic investments in providing leading-edge solutions, and our projections for future business conditions. Some factors that may affect these forward-looking statements include: difficult business conditions in the semiconductor industry and the overall economy and the efficacy of our plans for reacting to those conditions, changing customer demands, the actions of our competitors, and the challenges presented by the development and marketing of our new products. These forward-looking statements are based on current expectations and are subject to uncertainties and changes in condition, significance, value and effect as well as other risks detailed in documents filed with the Securities and Exchange Commission, including specifically the report on Form 10-K for the year ended June 29, 2008, and the reports on Form 10-Q for the quarters ended September 28, 2008, December 28, 2008, and March 29, 2009, which could cause actual results to vary from expectations. The Company undertakes no obligation to update the information or statements made in this press release.
Lam Research Corporation is a major provider of wafer fabrication equipment and services to the world's semiconductor industry. Lam's common stock trades on The NASDAQ Global Select MarketSM under the symbol LRCX. Lam is a NASDAQ-100® company. For more information, visit www.lamresearch.com.
LAM RESEARCH CORPORATION | ||||||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||||||||
(in thousands, except per share data and percentages) | ||||||||||||||||||||
Three Months Ended | Twelve Months Ended | |||||||||||||||||||
June 28, | March 29, | June 29, | June 28, | June 29, | ||||||||||||||||
2009 | 2009 | 2008 | 2009 | 2008 | ||||||||||||||||
(unaudited) | (unaudited) | (unaudited) | (unaudited) | (1) | ||||||||||||||||
Total revenue | $ | 217,764 | $ | 174,412 | $ | 566,160 | $ | 1,115,946 | $ | 2,474,911 | ||||||||||
Cost of goods sold | 150,007 | 127,680 | 318,900 | 706,219 | 1,282,494 | |||||||||||||||
Cost of goods sold - restructuring and asset impairments | - | 10,217 | 12,610 | 20,993 | 12,610 | |||||||||||||||
Cost of goods sold - 409A expense | - | - | - | - | 6,401 | |||||||||||||||
Total cost of goods sold | 150,007 | 137,897 | 331,510 | 727,212 | 1,301,505 | |||||||||||||||
Gross margin | 67,757 | 36,515 | 234,650 | 388,734 | 1,173,406 | |||||||||||||||
Gross margin as a percent of revenue | 31.1 | % | 20.9 | % | 41.4 | % | 34.8 | % | 47.4 | % | ||||||||||
Research and development | 67,491 | 70,434 | 86,652 | 288,269 | 323,759 | |||||||||||||||
Selling, general and administrative | 47,248 | 58,515 | 76,994 | 233,061 | 287,282 | |||||||||||||||
Goodwill impairment | 7,179 | 89,076 | - | 96,255 | - | |||||||||||||||
Restructuring and asset impairments | 5,396 | 13,028 | 6,366 | 44,513 | 6,366 | |||||||||||||||
409A expense | 982 | 646 | 710 | 3,232 | 44,494 | |||||||||||||||
Legal judgment | 4,647 | - | - | 4,647 | - | |||||||||||||||
In-process research and development | - | - | - | - | 2,074 | |||||||||||||||
Total operating expenses | 132,943 | 231,699 | 170,722 | 669,977 | 663,975 | |||||||||||||||
Operating income (loss) | (65,186 | ) | (195,184 | ) | 63,928 | (281,243 | ) | 509,431 | ||||||||||||
Operating margin as a percent of revenue | -29.9 | % | -111.9 | % | 11.3 | % | -25.2 | % | 20.6 | % | ||||||||||
Other income, net | 2,869 | 13,497 | 10,344 | 18,150 | 67,545 | |||||||||||||||
Income (loss) before income taxes | (62,317 | ) | (181,687 | ) | 74,272 | (263,093 | ) | 576,976 | ||||||||||||
Income tax expense | 26,173 | 16,672 | 2,094 | 39,055 | 137,627 | |||||||||||||||
Net income (loss) | $ | (88,490 | ) | $ | (198,359 | ) | $ | 72,178 | $ | (302,148 | ) | $ | 439,349 | |||||||
Net income (loss) per share: | ||||||||||||||||||||
Basic net income (loss) per share | $ | (0.70 | ) | $ | (1.58 | ) | $ | 0.58 | $ | (2.41 | ) | $ | 3.52 | |||||||
Diluted net income (loss) per share | $ | (0.70 | ) | $ | (1.58 | ) | $ | 0.57 | $ | (2.41 | ) | $ | 3.47 | |||||||
Number of shares used in per share calculations: | ||||||||||||||||||||
Basic | 126,273 | 125,566 | 125,046 | 125,595 | 124,647 | |||||||||||||||
Diluted | 126,273 | 125,566 | 126,657 | 125,595 | 126,504 | |||||||||||||||
(1) Derived from audited financial statements |
LAM RESEARCH CORPORATION | |||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||||
(in thousands) | |||||||||
June 28, | March 29, | June 29, | |||||||
2009 | 2009 | 2008 | |||||||
(unaudited) | (unaudited) |
(1) |
|||||||
ASSETS | |||||||||
Cash and cash equivalents | $ | 374,167 | $ | 374,648 | $ | 732,537 | |||
Short-term investments | 205,221 | 248,500 | 326,199 | ||||||
Accounts receivable, net | 253,585 | 196,842 | 412,356 | ||||||
Inventories | 233,410 | 260,667 | 282,218 | ||||||
Deferred income taxes | 69,043 | 90,541 | 96,748 | ||||||
Other current assets | 60,401 | 82,273 | 67,649 | ||||||
Total current assets | 1,195,827 | 1,253,471 | 1,917,707 | ||||||
Property and equipment, net | 215,666 | 225,864 | 235,735 | ||||||
Restricted cash and investments | 178,439 | 183,277 | 146,072 | ||||||
Deferred income taxes | 17,007 | 15,281 | 19,793 | ||||||
Goodwill and intangible assets | 260,787 | 268,249 | 403,187 | ||||||
Other assets | 84,145 | 87,340 | 84,261 | ||||||
Total assets | $ | 1,951,871 | $ | 2,033,482 | $ | 2,806,755 | |||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||
Current liabilities | $ | 340,763 | $ | 369,998 | $ | 637,679 | |||
Long-term debt and capital leases | $ | 40,886 | $ | 40,708 | $ | 276,503 | |||
Income taxes payable | 102,999 | 99,807 | 85,611 | ||||||
Other long-term liabilities | 14,134 | 19,711 | 23,018 | ||||||
Minority interests | - | - | 5,347 | ||||||
Stockholders' equity | 1,453,089 | 1,503,258 | 1,778,597 | ||||||
Total liabilities and stockholders' equity | $ | 1,951,871 | $ | 2,033,482 | $ | 2,806,755 | |||
(1) Derived from audited financial statements |
LAM RESEARCH CORPORATION | |||||||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||||||||||||||||
(in thousands) | |||||||||||||||||||||
|
|||||||||||||||||||||
Three Months Ended | Twelve Months Ended | ||||||||||||||||||||
June 28, | March 29, | June 29, | June 28, | June 29, | |||||||||||||||||
2009 | 2009 | 2008 | 2009 | 2008 | |||||||||||||||||
(unaudited) | (unaudited) | (unaudited) | (unaudited) | (1) | |||||||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||||||||||||
Net income (loss) | $ | (88,490 | ) | $ | (198,359 | ) | $ | 72,178 | $ | (302,148 | ) | $ | 439,349 | ||||||||
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities: |
|||||||||||||||||||||
Depreciation and amortization | 17,694 | 19,650 | 19,227 | 72,417 | 54,704 | ||||||||||||||||
Deferred income taxes | 19,913 | 12,929 | (4,652 | ) | 30,545 | (26,661 | ) | ||||||||||||||
Equity-based compensation expense | 13,358 | 10,227 | 11,629 | 53,042 | 42,516 | ||||||||||||||||
Income tax benefit on equity-based compensation plans | (1,173 | ) | (11,115 | ) | 26,815 | (14,294 | ) | 83,472 | |||||||||||||
Excess tax benefit on equity-based compensation plans | (237 | ) | 7,027 | (21,666 | ) | 6,273 | (58,904 | ) | |||||||||||||
Net gain on settlement of call option | - | - | 399 | - | (33,839 | ) | |||||||||||||||
Goodwill impairment | 7,179 | 89,076 | - | 96,255 | - | ||||||||||||||||
Restructuring and asset impairments | 5,396 | 23,245 | 18,976 | 65,506 | 18,976 | ||||||||||||||||
Other, net | 2,535 | 953 | (996 | ) | 9,353 | (3,319 | ) | ||||||||||||||
Changes in operating asset accounts | (34,295 | ) | 22,215 | 78,537 | (95,078 | ) | 74,025 | ||||||||||||||
Net cash provided by (used for) operating activities | (58,120 | ) | (24,152 | ) | 200,447 | (78,129 | ) | 590,319 | |||||||||||||
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||||||||||||||||
Capital expenditures and intangible assets | (5,848 | ) | (10,866 | ) | (18,951 | ) | (44,282 | ) | (76,803 | ) | |||||||||||
Acquisitions of businesses, net of cash acquired | - | (11,706 | ) | (6,918 | ) | (19,457 | ) | (482,574 | ) | ||||||||||||
Net sales (purchases) of available-for-sale securities | 93,056 | 33,961 | (32,494 | ) | 173,764 | 18,822 | |||||||||||||||
Purchase of call option | - | - | - | - | (13,506 | ) | |||||||||||||||
Proceeds from settlement of call option | - | - | 383 | - | 47,345 | ||||||||||||||||
Purchase of other investments | - | - | - | (3,439 | ) | (4,560 | ) | ||||||||||||||
Transfer of restricted cash and investments | (44,458 | ) | 558 | 17,233 | (92,206 | ) | 15,471 | ||||||||||||||
Other | 2,000 | (8,375 | ) | - | (8,375 | ) | - | ||||||||||||||
Net cash provided by (used for) investing activities | 44,750 | 3,572 | (40,747 | ) | 6,005 | (495,805 | ) | ||||||||||||||
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||||||||||||||
Principal payments on long-term debt and capital lease obligations | (911 | ) | (239,703 | ) | (1,500 | ) | (256,047 | ) | (251,714 | ) | |||||||||||
Net proceeds from issuance of long-term debt | - | - | 1,915 | 625 | 251,915 | ||||||||||||||||
Excess tax benefit on equity-based compensation plans | 237 | (7,027 | ) | 21,666 | (6,273 | ) | 58,904 | ||||||||||||||
Treasury stock purchases | (3,197 | ) | (546 | ) | (3,590 | ) | (30,946 | ) | (14,552 | ) | |||||||||||
Reissuances of treasury stock | 6,271 | 5,942 | 1,262 | 19,797 | 8,563 | ||||||||||||||||
Proceeds from issuance of common stock | 6,287 | 1,283 | 2,588 | 12,014 | 12,694 | ||||||||||||||||
Net cash provided by (used for) financing activities | 8,687 | (240,051 | ) | 22,341 | (260,830 | ) | 65,810 | ||||||||||||||
Effect of exchange rate changes on cash | 4,202 | (17,634 | ) | (1,857 | ) | (25,416 | ) | (1,754 | ) | ||||||||||||
Net increase (decrease) in cash and cash equivalents | (481 | ) | (278,265 | ) | 180,184 | (358,370 | ) | 158,570 | |||||||||||||
Cash and cash equivalents at beginning of period | 374,648 | 652,913 | 552,353 | 732,537 | 573,967 | ||||||||||||||||
Cash and cash equivalents at end of period | $ | 374,167 | $ | 374,648 | $ | 732,537 | $ | 374,167 | $ | 732,537 | |||||||||||
(1) Derived from audited financial statements |
Reconciliation of U.S. GAAP Net Loss to Ongoing Net Loss | ||||||||
(in thousands, except per share data and percentages) | ||||||||
Three Months Ended | Three Months Ended | |||||||
June 28, | March 29, | |||||||
2009 | 2009 | |||||||
U.S. GAAP net loss | $ | (88,490 | ) | $ | (198,359 | ) | ||
Pre-tax non-ongoing items: | ||||||||
Goodwill impairment - operating expenses | 7,179 | 89,076 | ||||||
Legal judgment - operating expenses | 4,647 | - | ||||||
Restructuring and asset impairments - cost of goods sold | - | 10,217 | ||||||
Restructuring and asset impairments - operating expenses | 5,396 | 13,028 | ||||||
409A expense - operating expenses | 982 | 646 | ||||||
One-time contract termination costs - operating expenses | 413 | - | ||||||
Impairment of investment - other income, net | - | 1,543 | ||||||
Exchange rate gain associated with accelerated tax planning strategy - other income, net | - | (6,674 | ) | |||||
Net tax benefit on non-ongoing items | (4,556 | ) | (5,506 | ) | ||||
Net tax expense on resolution of certain tax matters | 3,637 | - | ||||||
Net tax expense for valuation allowance | 13,787 | - | ||||||
Net tax expense on change in state tax law | - | 5,244 | ||||||
Net tax expense on accelerated tax planning strategy | - | 1,014 | ||||||
Ongoing net loss | $ | (57,005 | ) | $ | (89,771 | ) | ||
Ongoing net loss per diluted share | $ | (0.45 | ) | $ | (0.71 | ) | ||
Number of shares used for diluted per share calculation | 126,273 | 125,566 |
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Loss to |
||||||||
(in thousands, except percentages) | ||||||||
Three Months Ended | Three Months Ended | |||||||
June 28, | March 29, | |||||||
2009 | 2009 | |||||||
U.S. GAAP gross margin | $ | 67,757 | $ | 36,515 | ||||
Pre-tax non-ongoing items: | ||||||||
Pre-tax restructuring and asset impairments - cost of goods sold | - | $ | 10,217 | |||||
Ongoing gross margin | $ | 67,757 | $ | 46,732 | ||||
U.S. GAAP gross margin as a percent of revenue | 31.1 | % | 20.9 | % | ||||
Ongoing gross margin as a percent of revenue | 31.1 | % | 26.8 | % | ||||
U.S. GAAP operating expenses | $ | 132,943 | $ | 231,699 | ||||
Pre-tax non-ongoing items: | ||||||||
Goodwill impairment - operating expenses | (7,179 | ) | (89,076 | ) | ||||
Legal judgment - operating expenses | (4,647 | ) | - | |||||
Restructuring and asset impairments - operating expenses | (5,396 | ) | (13,028 | ) | ||||
One-time contract termination costs - operating expenses | (413 | ) | - | |||||
409A expense - operating expenses | (982 | ) | (646 | ) | ||||
Ongoing operating expenses | $ | 114,326 | $ | 128,949 | ||||
Ongoing operating loss | $ | (46,569 | ) | $ | (82,217 | ) | ||
Ongoing operating margin as a percent of revenue | -21.4 | % | -47.1 | % |
SOURCE: Lam Research Corporation
Lam Research Corporation Carol Raeburn, 510-572-4450 Senior Director, Investor Relations carol.raeburn@lamresearch.com
Copyright Business Wire 2009